Elasmogen wins two grants worth £374,000

Elasmogen wins two grants worth £374,000

New awards for COVID-19 and oncology programs support re-opening of labs in Aberdeen Aberdeen, UK, 8th July 2020:  Aberdeen drug discovery pioneer, Elasmogen Ltd has won two new grants worth £374,000 to support programs for COVID-19 and oncology.  In April 2020...

read more
Elasmogen Secures £2 M Funding

Elasmogen Secures £2 M Funding

Funding from Deepbridge Capital will support development of next generation biologics January 10th 2020: Aberdeen, Scotland:  Elasmogen Ltd, the biopharmaceutical company leading the development of soloMERTM biologics, today announced it has secured follow-on equity...

read more